The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Lung cancer incidence and mortality in China, 2009
Open accessAbstract
Background: The N ational C entral C ancer R egistry (NCCR) is a governmental organization for cancer surveillance affiliated to the B ureau of D isease C ontrol, M inistry of H ealth, in C hina. It annually collects cancer registration data from local registries and then analyzes and publishes the results to provide useful information for making anti‐cancer policy, program evaluation, and etiology research. At the end of 2012, the NCCR reported cancer statistics for 2009. Methods: By mid 2012, 104 population‐based cancer registries reported cancer incidence and mortality data, including demographic information, for 2009, to the NCCR. After an evaluation procedure, a total of 72 registries’ data met the criteria, which was then compiled for analysis. Individual lung cancer cases were retrieved from the national database based on the International Classification of Diseases (ICD)‐10 topography code as “C33, C34,“ including cancers of the trachea and bronchus. The crude incidence and mortality rates of lung cancer were calculated by gender, age, and location (urban/rural). C hina's population in 1982 and S egi's population structures were used for age‐standardized rates. Results: In cancer registration areas in 2009, lung cancer was the most common cancer in C hina and in urban areas, the second most common cancer in rural areas. It was the leading cause of cancer death both in males and females, urban and rural areas. The incidence and mortality rates of lung cancer were higher in males than those in females, and in urban areas than in rural areas. The age‐specific incidence and mortality rates showed that both rates were relatively low for those aged under 50 years, but dramatically increased and reached a peak in the age group of 80–84 years. Conclusion: Lung cancer is the most common cancer in C hina and leading cause of cancer death. Primary and secondary prevention should be carried out in each group, such as tobacco control and early detection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
Cancer Incidence in Five Continents
(1966) · doi:10.1007/978-3-642-85849-9 · Cited by 5,936
Cancer Incidence in Five Continents. Comparability and quality of data.
Dm, P., & Cs, M. (1992) · PubMed · Cited by 505
Li, G. L., & Chen, W. Q. (2009) · PubMed · Cited by 29
Self-citation
Cited by
DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer
Huang, R.-X., & Zhou, P.-K. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0150-x · Cited by 1,198
Lung cancer LDCT screening and mortality reduction — evidence, pitfalls and future perspectives
Oudkerk, M., Liu, S., Heuvelmans, M. A., Walter, J. E., & Field, J. K. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-00432-6 · Cited by 519
Cancer deaths and cases attributable to lifestyle factors and infections in China, 2013
Islami, F., Chen, W., Yu, X. Q., Lortet-Tieulent, J., Zheng, R., Flanders, W. D., Xia, C., Thun, M. J., Gapstur, S. M., Ezzati, M., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx342 · Cited by 438
Self-citationReview of aerobic glycolysis and its key enzymes – new targets for lung cancer therapy
Li, X., Gu, J., & Zhou, Q. (2015) · Thoracic Cancer · doi:10.1111/1759-7714.12148 · Cited by 331
Descriptive epidemiology of breast cancer in China: incidence, mortality, survival and prevalence
Li, T., Mello-Thoms, C., & Brennan, P. C. (2016) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-3947-0 · Cited by 309
Metadata
- Authors
- Chen, W., Zheng, R., Zhang, S., Zou, X., Zhao, P., & He, J.
- Venue
- Thoracic Cancer
- Publisher
- Wiley
- Published
- 2013-04-22
- Volume
- 4
- Issue
- 2
- Pages
- 102-108
- ISSN
- 1759-7706 (ISSN-L)
- 1759-7714
- OpenAlex
- W2326188967
- Cited by
- 309
- References
- 4
- FWCI
- 2.70
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.